EUVIMEDEUVIMED entdecken
Crossref

Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients

Christine Andrews, Michael Herzlinger, Muhammad Riaz, Enju Liu, Christina Chan, Silvana Bonilla iD

Journal of Pediatric Gastroenterology and Nutrition · 2024-07 · 79 (1) · 35-41

DOI: 10.1002/jpn3.12242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 08.05.2024. Verfasst von Christine Andrews und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hasbro Children's Hospital, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Proton Pump Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Helicobacter pylori rates of eradication to common first‐line regimens continue to decline globally. Prescription of the appropriate medication dosage is an important consideration, particularly in the pediatric population due to medication weight‐based dosing. Limited data is available on the impact of guideline‐recommended weight‐based dosing on the successful eradication of H. pylori in children.

Methods

Retrospective study of patients with histologic evidence of H. pylori from two pediatric tertiary care centers in New England. We excluded patients who were not treated or those missing eradication data. We compared the eradication rates of patients prescribed recommended weight‐based dosages, duration, and frequency of treatment with those who were not.

Results

One hundred forty‐four patients were included. The overall eradication rate was 73.6% (106/144). All treatment regimens were properly prescribed for 14 days. There was a high rate of improper weight‐based dosing: proton pump inhibitor (PPI) 31.2% (45/144), amoxicillin 31.7% (39/123), metronidazole (MET) 19.4% (12/62), clarithromycin (CLA) 23.9% (22/70), tetracycline 50% (6/12), bismuth 26.1% (6/23). When PPIs were properly weight‐dosed, there was a 78.8% eradication rate that dropped to 62.2% with suboptimal dosing ( p = 0.036, odds ratio [OR]: 2.26, confidence interval [CI]: 1.04−4.87). When amoxicillin was properly weight‐dosed, successful eradication was achieved in 81% versus only 53.8% when improperly dosed ( p = 0.002; OR: 3.64, CI: 1.58−8.37). There was no statistically significant impact on eradication rates with improper weight‐based dosing of MET, CLA, tetracycline, or bismuth.

Conclusion

Proper weight‐based dosing of amoxicillin and PPI is important for the successful eradication of H. pylori among children in the New England area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsProton Pump InhibitorsAmoxicillinMetronidazoleHumansRetrospective StudiesChildFemaleMaleAdolescentChild, PreschoolClarithromycinDrug Therapy, CombinationTetracyclineBismuthBody WeightTreatment Outcome

Stichwörter der Autor:innen

acid suppressionamoxicillintreatment dosing

Substanzen

Anti-Bacterial AgentsProton Pump InhibitorsAmoxicillinMetronidazoleClarithromycinTetracyclineBismuth

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hasbro Children's Hospital, Providence, Rhode Island, USA.
  • The Warren Alpert Medical School of Brown University and Hasbro Children's Hospital, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Providence, Rhode Island, USA.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Oklahoma, Oklahoma City, Oklahoma, USA.
  • Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School and Boston Children's Hospital, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Boston, Massachusetts, USA.

ORCID-Profile: Silvana Bonilla

Förderung

  • None

Zitieren

APA

Andrews, C., Herzlinger, M., Riaz, M., Liu, E., Chan, C., & Bonilla, S. (2024). Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients. Journal of Pediatric Gastroenterology and Nutrition, 79(1), 35-41. https://doi.org/10.1002/jpn3.12242

Vancouver

Andrews C, Herzlinger M, Riaz M, Liu E, Chan C, Bonilla S. Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients. Journal of Pediatric Gastroenterology and Nutrition. 2024;79(1):35-41. doi:10.1002/jpn3.12242

BibTeX
@article{Andrews2024,
  author = {Andrews, Christine and Herzlinger, Michael and Riaz, Muhammad and Liu, Enju and Chan, Christina and Bonilla, Silvana},
  title = {Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  volume = {79},
  number = {1},
  pages = {35--41},
  doi = {10.1002/jpn3.12242}
}
Kostenlos starten →